EUVIMEDEUVIMED entdecken
Open Access

Engineering a Novel Cofactor‐Versatile Short‐Chain Dehydrogenase for Efficient Synthesis of Chiral Alcohols

Li-Li Yao, Xian-Heng Song, Kai-Cheng Huang, Yuan-Fan Ye, Hui-Qi Mao, Yan-Jun Wan, Feng Xue iD, Bin Xue iD, Ya-Jun Wang iD

Biotechnology and Bioengineering · 2026-08 · 123 (8) · 2062-2079

DOI: 10.1002/bit.70239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 13.05.2026. Verfasst von Li-Li Yao und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Bacillus subtilis, Alcohols, Short Chain Dehydrogenase-Reductases, Protein Engineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program of China, "Pioneer" and "Leading Goose" Key R&D Program of Zhejiang, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Short‐chain dehydrogenases/reductases (SDRs) are widely used for the asymmetric synthesis of chiral alcohols, which are critical building blocks in pharmaceutical manufacturing. In this study, a novel SDR from Bacillus subtilis ( Bs SDR) was identified and engineered for the asymmetric synthesis of ( S )−1‐(2,6‐dichloro‐3‐fluorophenyl)ethanol (( S )‐CFL). By integrating in silico molecular docking with FuncLib based design, a focused mutant library of Bs SDR targeting key hotpots was constructed. Four of the constructed 31 variants exhibited markedly enhanced activity. Subsequent combinatorial mutagenesis generated a “best” variant Bs SDR M2 (I178L/T179L), which displayed a 107.4‐fold increase in catalytic activity, along with excellent enantioselectivity (> 99.9% e.e .) and broad substrate scope. Notably, unlike most SDRs that are strictly dependent on NAD(H) or NADP(H), the Bs SDR also possesses a remarkable capacity to utilize the noncanonical cofactor NMNH. Moreover, in addition to robust enantioselective reductive activity toward CFA, the Bs SDR also exhibits glucose‐oxidizing activity, driving cofactors regeneration. In the presence of NMNH, Bs SDR M2 displayed a 33.3‐fold improvement in catalytic efficiency ( k cat / K M ) toward substrate 1‐(2,6‐dichloro‐3‐fluorophenyl)ethanone (CFA) compared to the wild‐type (WT), along with an extended half‐life ( t 1/2 ) of 52.1 h at 45°C. Using Escherichia coli expressing Bs SDR M2 as the only biocatalyst and glucose as the cosubstrate, 100 g/L CFA was reduced within 6 h in 92.1% conversion and > 99.9% e.e ., achieving a space‐time yield (STY) of 368.2 g/(L·d). This work highlights the potential of Bs SDR as a cost‐effective and sustainable biocatalyst for the efficient synthesis of ( S )‐CFL and other high‐value chiral alcohols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacillus subtilisAlcoholsShort Chain Dehydrogenase-ReductasesProtein EngineeringBacterial ProteinsStereoisomerismCoenzymesEscherichia coliMolecular Docking Simulation

Stichwörter der Autor:innen

(S)−1‐(2,6‐dichloro‐3‐fluorophenyl) ethanolNMNH‐utilizationcatalytic performanceprotein engineeringshort‐chain dehydrogenase

Substanzen

AlcoholsShort Chain Dehydrogenase-ReductasesCoenzymesBacterial Proteins

Autor:innen und Institutionen

  • College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang, China.
  • Zhejiang Key Laboratory of Green Manufacturing Technology for Chemical Drugs, Deqing, Zhejiang, China.
  • Key Laboratory for Green Pharmaceutical Technology and Equipment (Zhejiang University of Technology) of Ministry of Education, Deqing, Zhejiang, China.
  • National Engineering Research Center for the Synthesis of Chemical Active Pharmaceutical Ingredients, Deqing, Zhejiang, China.
  • College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, Zhejiang, China.
  • School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, China.

ORCID-Profile: Feng Xue, Bin Xue, Ya-Jun Wang

Förderung

  • National Key Research and Development Program of China
  • "Pioneer" and "Leading Goose" Key R&D Program of Zhejiang
  • National Natural Science Foundation of China
  • Central Guidance for Local Science and Technology Development Funds Project

Zitieren

APA

Yao, L. L., Song, X. H., Huang, K. C., Ye, Y. F., Mao, H. Q., Wan, Y. J., Xue, F., Xue, B., & Wang, Y. J. (2026). Engineering a Novel Cofactor‐Versatile Short‐Chain Dehydrogenase for Efficient Synthesis of Chiral Alcohols. Biotechnology and Bioengineering, 123(8), 2062-2079. https://doi.org/10.1002/bit.70239

Vancouver

Yao LL, Song XH, Huang KC, Ye YF, Mao HQ, Wan YJ, et al. Engineering a Novel Cofactor‐Versatile Short‐Chain Dehydrogenase for Efficient Synthesis of Chiral Alcohols. Biotechnology and Bioengineering. 2026;123(8):2062-2079. doi:10.1002/bit.70239

BibTeX
@article{Yao2026,
  author = {Yao, Li-Li and Song, Xian-Heng and Huang, Kai-Cheng and Ye, Yuan-Fan and Mao, Hui-Qi and Wan, Yan-Jun and Xue, Feng and Xue, Bin and Wang, Ya-Jun},
  title = {Engineering a Novel Cofactor‐Versatile Short‐Chain Dehydrogenase for Efficient Synthesis of Chiral Alcohols},
  journal = {Biotechnology and Bioengineering},
  year = {2026},
  volume = {123},
  number = {8},
  pages = {2062--2079},
  doi = {10.1002/bit.70239}
}
Kostenlos starten →